Esperion Therapeutics (ESPR) Shareholder Meditor Group LTD Increased Its Stake by $2.25 Million as Valuation Declined; As Shutterfly (SFLY) Valuation Declined, Hhr Asset Management Has Increased Its Holding by $3.63 Million

Shutterfly, Inc. (NASDAQ:SFLY) Logo

Hhr Asset Management Llc increased its stake in Shutterfly Inc (SFLY) by 8.68% based on its latest 2018Q4 regulatory filing with the SEC. Hhr Asset Management Llc bought 90,824 shares as the company’s stock declined 10.60% while stock markets rallied. The hedge fund held 1.14M shares of the miscellaneous company at the end of 2018Q4, valued at $45.80 million, up from 1.05M at the end of the previous reported quarter. Hhr Asset Management Llc who had been investing in Shutterfly Inc for a number of months, seems to be bullish on the $1.39 billion market cap company. The stock increased 0.82% or $0.33 during the last trading session, reaching $40.66. About 268,222 shares traded. Shutterfly, Inc. (NASDAQ:SFLY) has declined 43.06% since April 17, 2018 and is downtrending. It has underperformed by 47.43% the S&P500. Some Historical SFLY News: 01/05/2018 – Shutterfly Sees 2018 Business Solutions Rev $210M-$220M; 03/05/2018 – Shutterfly Presenting at Conference May 8; 01/05/2018 – SHUTTERFLY SEES 2018 ADJ EPS $2.83 TO $3.28; 01/05/2018 – Shutterfly Sees 2018 Non-GAAP Rev $2.01B-$2.06B; 04/04/2018 – Amazon: Shutterfly Taps AWS to Power Cloud Transformation Initiative; 02/04/2018 – Shutterfly Inc. Closes Transformational Acquisition Of Lifetouch; 14/05/2018 – SHUTTERFLY URGES HLDRS OK ’15 EQUITY INCENTIVE PLAN AMENDMENT; 14/05/2018 – SHUTTERFLY URGES HLDRS BACK COMPANY’S SLATE; 01/05/2018 – SHUTTERFLY 1Q LOSS/SHR 83C, EST. LOSS/SHR 95C; 01/05/2018 – Shutterfly Sees 2018 Consumer Rev $1.02B-$1.05B

Meditor Group Ltd increased its stake in Esperion Therapeutics Inc (ESPR) by 1.9% based on its latest 2018Q4 regulatory filing with the SEC. Meditor Group Ltd bought 50,000 shares as the company’s stock declined 11.78% while stock markets rallied. The institutional investor held 2.68 million shares of the health care company at the end of 2018Q4, valued at $123.27 million, up from 2.63 million at the end of the previous reported quarter. Meditor Group Ltd who had been investing in Esperion Therapeutics Inc for a number of months, seems to be bullish on the $1.08B market cap company. The stock decreased 3.73% or $1.56 during the last trading session, reaching $40.08. About 428,635 shares traded. Esperion Therapeutics, Inc. (NASDAQ:ESPR) has declined 39.96% since April 17, 2018 and is downtrending. It has underperformed by 44.33% the S&P500. Some Historical ESPR News: 07/05/2018 – Pomerantz Law Firm Announces the Filing of a Class Action against Esperion Therapeutics, Inc. and Certain Officers — ESPR; 04/05/2018 – Esperion to Participate in Fireside Chat at the Deutsche Bank 43rd Annual Health Care Conference; 04/04/2018 – Esperion Therapeutics Non-Deal Roadshow Set By JMP for Apr. 11; 10/04/2018 – Esperion Therapeutics at Deutsche Bank Conference May 8; 13/03/2018 – New Research Coverage Highlights Star Bulk Carriers, IPG Photonics, Mellanox Technologies, Hollysys Automation Technologies, Es; 02/04/2018 – Fidelity Growth Adds Esperion Therapeutics, Exits Cavium; 27/03/2018 – Esperion Therapeutics Access Event Set By Chardan for Apr. 3; 08/05/2018 – Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Esperion Therapeutics, Inc. (ESPR) and; 08/05/2018 – Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Esperion Therapeutics, Inc. (ESPR) and Encourages Investors to Contact the Firm; 24/05/2018 – The Klein Law Firm Announces a Class Action Commenced on Behalf of Esperion Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of July 6, 2018 (ESPR)

Meditor Group Ltd, which manages about $485.47 million US Long portfolio, decreased its stake in Alkermes Plc (NASDAQ:ALKS) by 138,239 shares to 892,400 shares, valued at $26.33 million in 2018Q4, according to the filing.

More notable recent Esperion Therapeutics, Inc. (NASDAQ:ESPR) news were published by: Seekingalpha.com which released: “Esperion up 8% premarket – Seeking Alpha” on October 26, 2018, also Gurufocus.com with their article: “Weekly CEO Buys Highlight – GuruFocus.com” published on April 07, 2019, Gurufocus.com published: “Mar 21, 2019 – Esperion Therapeutics Inc (ESPR) President & CEO Timothy M Mayleben Bought $217,400 of Shares – GuruFocus.com” on March 21, 2019. More interesting news about Esperion Therapeutics, Inc. (NASDAQ:ESPR) were released by: Benzinga.com and their article: “70 Biggest Movers From Yesterday – Benzinga” published on March 20, 2019 as well as Nasdaq.com‘s news article titled: “Esperion to Present at the Needham & Company 18th Annual Healthcare Conference – Nasdaq” with publication date: April 02, 2019.

Investors sentiment decreased to 1 in Q4 2018. Its down 0.11, from 1.11 in 2018Q3. It dived, as 22 investors sold ESPR shares while 40 reduced holdings. 23 funds opened positions while 39 raised stakes. 24.06 million shares or 2.18% less from 24.60 million shares in 2018Q3 were reported. Parallax Volatility Advisers LP has invested 0% in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Citadel Limited Liability Corporation holds 0% or 62,945 shares. Raymond James Finance Advisors has 0% invested in Esperion Therapeutics, Inc. (NASDAQ:ESPR) for 13,320 shares. Royal Bank & Trust Of Canada reported 2,073 shares. Vanguard has 0% invested in Esperion Therapeutics, Inc. (NASDAQ:ESPR) for 1.70M shares. Parkside Bankshares Trust stated it has 500 shares or 0.01% of all its holdings. 9,451 were reported by Voya Invest Mngmt Ltd Com. National Bank & Trust Of Nova Scotia holds 100,000 shares. Spark Inv Limited Liability Company invested in 0.72% or 227,100 shares. Gam Holding Ag owns 88,000 shares for 0.2% of their portfolio. North Star Inv Mgmt holds 70 shares or 0% of its portfolio. Ubs Asset Mngmt Americas has 0% invested in Esperion Therapeutics, Inc. (NASDAQ:ESPR) for 13,893 shares. Meditor Grp Incorporated Ltd stated it has 25.39% of its portfolio in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Partner Invest Management Limited Partnership holds 1.46% or 25,341 shares in its portfolio. Toth Advisory reported 25 shares stake.

Since October 18, 2018, it had 0 insider buys, and 3 insider sales for $2.26 million activity. MENON SATISH sold $1.20 million worth of Shutterfly, Inc. (NASDAQ:SFLY) on Monday, November 19. Another trade for 6,260 shares valued at $384,289 was sold by Lokuge Ishantha. $1.02 million worth of stock was sold by POPE MICHAEL W on Saturday, October 27.

More notable recent Shutterfly, Inc. (NASDAQ:SFLY) news were published by: Seekingalpha.com which released: “Surviving A Bad Stock Pick: Shutterfly – Seeking Alpha” on December 19, 2018, also Seekingalpha.com with their article: “Shutterfly, Inc. 2018 Q4 – Results – Earnings Call Slides – Seeking Alpha” published on February 06, 2019, Finance.Yahoo.com published: “Here is What Hedge Funds Think About Shutterfly, Inc. (SFLY) – Yahoo Finance” on December 12, 2018. More interesting news about Shutterfly, Inc. (NASDAQ:SFLY) were released by: Seekingalpha.com and their article: “Shutterfly Q4 2018 Earnings Preview – Seeking Alpha” published on February 04, 2019 as well as Nasdaq.com‘s news article titled: “Noteworthy Wednesday Option Activity: FDX, ROKU, SFLY – Nasdaq” with publication date: December 26, 2018.

Shutterfly, Inc. (NASDAQ:SFLY) Institutional Positions Chart